New York, July 19, 2012 — MTS Health Partners, L.P. (“MTS”), the New-York based healthcare merchant bank, announced today that Vince Lambert has joined the firm as Senior Managing Director.
Mr. Lambert has over 17 years of experience in investment banking and has been exclusively focused on healthcare services since 1999. He has extensive transaction experience across a wide range of healthcare services businesses, including providers, outsourcing and distribution and managed care. He has overseen over $25 billion of advisory assignments and raised over $20 billion of capital for companies in the healthcare services sector.

Curtis Lane, founder and Senior Managing Director of MTS, said, “We are excited to bring Vince on board at this pivotal time for healthcare companies. Vince’s experience in several important areas will be invaluable as we navigate the new regulatory environment in which healthcare companies are financed and operated.”

Prior to joining MTS, Mr. Lambert was a Managing Director in the Healthcare Group at Bank of America Merrill Lynch. He joined the bank in 1999 and was most recently responsible for the investment banking coverage effort of dialysis, diagnostic labs, home health and outsourcing and distribution. Before that, Mr. Lambert worked in the Healthcare Investment Banking Group at CS First Boston. He began his investment banking career at Dean Witter Reynolds in 1993. Mr. Lambert earned an MBA, magna cum laude, from the University of Chicago and a BS in Economics, magna cum laude, from The Wharton School at the University of Pennsylvania.

Mr. Lambert said, “I am delighted to join the team at MTS. They have proven to be exceptional advisors to companies in the healthcare industry. I look forward to working with them to continue to deliver sound strategic advice to clients attempting to navigate the volatile regulatory environment and complex changes facing the industry.”

About MTS

MTS Health Partners, L.P., located in New York, offers strategic advisory and capital raising services as well as private equity capital to companies in the global healthcare industry. For further information, please visit: